Danish pharmaceutical company Novo Nordisk will reduce 9,000 jobs within the business transformation program, which is expected to save annual costs of 8 billion Danish Krones ($ 1.3 billion) by the end of 2026, the company's press office said. The purpose of the planned transformation is ...